Prednisone is a synthetic corticosteroid drug which is usually taken orally and can be used for a large number of different conditions. It has a mainly glucocorticoid effect. Prednisone is a “prodrug” that is converted by the liver into prednisolone, which is the active drug and a steroid.

REVLIMID® (lenalidomide) in combination with dexamethasone is indicated for the treatment of multiple myeloma patients who have received at least one prior therapy.

THALOMID® (thalidomide) in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma.

VELCADE® (bortezomib) for Injection is indicated for the treatment of patients with multiple myeloma. VELCADE is contraindicated in patients with hypersensitivity to bortezomib, boron, or mannitol.

ZOMETA is a treatment for multiple myeloma that may reduce or delay bone problems‚ such as fractures that can result from bone damage. ZOMETA can also help patients who already have experienced bone complications. ZOMETA is not chemotherapy and may be used with other cancer treatments‚ such as radiation‚ hormonal therapy‚ or chemotherapy.